Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis

Menopause

Volumn 21, Issue 9, 2014, Pages 962-966

  Igase, Michiya ^a,b   Kohara, Katsuhiko ^a,b   Tabara, Yasuharu ^c   Ohara, Maya ^a,b   Takita, Rie ^a,b   Ochi, Masayuki ^a,b   Okada, Yoko ^a,b   Miki, Tetsuro ^a,b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Alendronate; Brachial ankle pulse wave velocity; Minodronate; Osteoporosis; Postmenopausal

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; MINODRONIC ACID; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ADULT; ANKLE; ARTERIAL STIFFNESS; ARTICLE; BONE DENSITY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FRACTURE; HEART PROTECTION; HUMAN; JAPANESE (PEOPLE); LUMBAR SPINE; POSTMENOPAUSE OSTEOPOROSIS; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; AGED; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BRACHIAL ARTERY; DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS, POSTMENOPAUSAL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PULSATILE FLOW; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ALENDRONATE; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BONE DENSITY CONSERVATION AGENTS; BRACHIAL ARTERY; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMIDAZOLES; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; PULSATILE FLOW; TREATMENT OUTCOME;

EID: 84906937664     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000197     Document Type: Article

References (26)

1. Hmamouchi I, Allali F, Khazzani H, et al. Low bone mineral density is related to atherosclerosis in postmenopausal Moroccan women. BMC Public Health 2009;9:388.
2. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-795.
3. Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 2007;14:373-384.
4. Sinnott B, Syed I, Sevrukov A, Barengolts E. Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int 2006;78:195-202.
5. Von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999;106:273-278.
6. Igarashi Y, Chikamori T, Tomiyama H, et al. Diagnostic value of simultaneous brachial and ankle blood pressure measurements for the extent and severity of coronary artery disease as assessed by myocardial perfusion imaging. Circ J 2005;69:237-242.
7. Takashima N, Turin TC, Matsui K, et al. The relationship of brachialankle pulse wave velocity to future cardiovascular disease events in the general Japanese population: the Takashima Study [epub ahead of print October 31, 2013]. J Hum Hypertens 2013. doi: 10.1038/jhh.2013.103.
8. Albu A, Fodor D, Bondor C, Crǎciun AM. Bone metabolism regulators and arterial stiffness in postmenopausal women. Maturitas 2013; 76:146-150.
9. Seo SK, Cho S, Kim HY, et al. Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women. Menopause 2009;16:937-943.
10. Christenson ES, Jiang X, Kagan R, Schnatz P. Osteoporosis management in post-menopausal women. Minerva Ginecol 2012;64:181-194.
11. Fiore CE, Pennisi P, Pulvirenti I, Francucci CM. Bisphosphonates and atherosclerosis. J Endocrinol Invest 2009;32:38-43.
12. Matsumoto T, Hagino H, Shiraki M, et al. Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 2009;20:1429-1437.
13. Dunford JE, Thompson K, Coxon FP, et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 2001;296:235-242.
14. Yoshioka T, Okimoto N, Okamoto K, Sakai A. A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients. J Bone Miner Metab 2013;31:153-160.
15. Hagino H, Nishizawa Y, Sone T, et al. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone 2009;44:1078-1084.
16. Okazaki R, Hagino H, Ito M, et al. Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis. Osteoporos Int 2012;23:1737-1745.
17. Tabara Y, Igase M, Kido T, Ochi N, Miki T, Kohara K. Composition of lower extremity in relation to a high ankle-brachial index. J Hypertens 2009;27:167-173.
18. Kido T, Tabara Y, Igase M, et al. Postural instability is associated with brain atrophy and cognitive impairment in the elderly: the J-SHIPP study. Dement Geriatr Cogn Disord 2010;29:379-387.
19. Ochi M, Kohara K, Tabara Y, et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 2010;212:327-332.
20. Soen S, Fukunaga M, Sugimoto T, et al. Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab 2013;31:247-257.
21. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002;25:359-364.
22. Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M. Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res 2003;26:163-167.
23. Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 2002;87:1586-1592.
24. Hirose K, Tomiyama H, Okazaki R, et al. Increased pulse wave velocity associated with reduced calcaneal quantitative osteo-sono index: possible relationship between atherosclerosis and osteopenia. J Clin Endocrinol Metab 2003;88:2573-2578.
25. Okamoto K, Inaba M, Furumitsu Y, et al. Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study. Life Sci 2010;87:686-691.
26. Ylitalo R, Kalliovalkama J, Wu X, Kankaanranta H, Salenius JP, Sisto T. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. Pharmacol Toxicol 1998;83: 125-131.